Short-term infusion of a fish oil-based lipid emulsion modulates fatty acid status, but not immune function or (anti)oxidant balance: a randomized cross-over study
Short-term infusion of a fish oil-based lipid emulsion modulates fatty acid status, but not immune function or (anti)oxidant balance: a randomized cross-over study
Background and aims: Studies suggest clinical benefits of parenteral fish oil (FO), rich in n-3 polyunsaturated fatty acids (PUFAs), over soyabean oil (SO), rich in n-6 PUFAs, in patients with pro-inflammatory conditions such as sepsis and trauma. Because the mechanisms behind these observations remain unclear, the present study explored the effects of intravenous infusion of FO and SO on fatty acid incorporation, immune functions and (anti)oxidant balance in healthy human volunteers.
Methods: Saline, a SO emulsion and a FO emulsion were administered for one hour on three consecutive days at a rate of 0·2 g/kg BW/h to eight subjects in a randomized cross-over design with a 3-week interval between treatments. Plasma phospholipid and peripheral blood mononuclear cell (PBMC) fatty acid compositions, and leucocyte counts and functions were assessed prior to the first infusion (T = 0, baseline) and 1 day (T = 4, early effects) and 8 days (T = 11, late effects) after the third infusion.
Results: Fish oil infusion significantly increased n-3 PUFA proportions and decreased n-6 PUFA proportions in plasma phospholipids and PBMCs. There were no differences in immune functions or (anti)oxidant balance between treatments at any time.
Conclusions:?The present lipid infusion protocol appears to be safe and well tolerated and provides significant incorporation of n-3 PUFAs into plasma phospholipids and PBMCs. In the absence of overt inflammation, no direct effects of FO were observed on immune function or (anti)oxidant balance. This model may be useful to evaluate effects of parenteral lipids in other settings, for example in individuals displaying an inflammatory state.
fish oil, human, immune modulation, lipid incorporation, parenteral lipid
290-302
Versleijen, Michelle W.
ab95be09-8a4a-4bd8-b69b-eca24cb00367
Roelofs, Hennie M.
c78cf8c6-c435-4eb9-82b9-d6c3f331c89f
Rombouts, Charlotte
91b58d84-3cca-47ed-948c-6ac5614fd3ad
Hermans, Peter W.
1716b7af-3768-4d9d-bb2a-066e1b6254d3
Noakes, Paul S.
0ed50cd9-de73-4851-8039-ee72860d8ae5
Calder, Philip C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Wanten, Geert J.
c5cbb5ed-e7d4-466f-a3c4-a18c1b225c9e
March 2012
Versleijen, Michelle W.
ab95be09-8a4a-4bd8-b69b-eca24cb00367
Roelofs, Hennie M.
c78cf8c6-c435-4eb9-82b9-d6c3f331c89f
Rombouts, Charlotte
91b58d84-3cca-47ed-948c-6ac5614fd3ad
Hermans, Peter W.
1716b7af-3768-4d9d-bb2a-066e1b6254d3
Noakes, Paul S.
0ed50cd9-de73-4851-8039-ee72860d8ae5
Calder, Philip C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Wanten, Geert J.
c5cbb5ed-e7d4-466f-a3c4-a18c1b225c9e
Versleijen, Michelle W., Roelofs, Hennie M., Rombouts, Charlotte, Hermans, Peter W., Noakes, Paul S., Calder, Philip C. and Wanten, Geert J.
(2012)
Short-term infusion of a fish oil-based lipid emulsion modulates fatty acid status, but not immune function or (anti)oxidant balance: a randomized cross-over study.
European Journal of Clinical Investigation, 42 (3), .
(doi:10.1111/j.1365-2362.2011.02582.x).
(PMID:21880037)
Abstract
Background and aims: Studies suggest clinical benefits of parenteral fish oil (FO), rich in n-3 polyunsaturated fatty acids (PUFAs), over soyabean oil (SO), rich in n-6 PUFAs, in patients with pro-inflammatory conditions such as sepsis and trauma. Because the mechanisms behind these observations remain unclear, the present study explored the effects of intravenous infusion of FO and SO on fatty acid incorporation, immune functions and (anti)oxidant balance in healthy human volunteers.
Methods: Saline, a SO emulsion and a FO emulsion were administered for one hour on three consecutive days at a rate of 0·2 g/kg BW/h to eight subjects in a randomized cross-over design with a 3-week interval between treatments. Plasma phospholipid and peripheral blood mononuclear cell (PBMC) fatty acid compositions, and leucocyte counts and functions were assessed prior to the first infusion (T = 0, baseline) and 1 day (T = 4, early effects) and 8 days (T = 11, late effects) after the third infusion.
Results: Fish oil infusion significantly increased n-3 PUFA proportions and decreased n-6 PUFA proportions in plasma phospholipids and PBMCs. There were no differences in immune functions or (anti)oxidant balance between treatments at any time.
Conclusions:?The present lipid infusion protocol appears to be safe and well tolerated and provides significant incorporation of n-3 PUFAs into plasma phospholipids and PBMCs. In the absence of overt inflammation, no direct effects of FO were observed on immune function or (anti)oxidant balance. This model may be useful to evaluate effects of parenteral lipids in other settings, for example in individuals displaying an inflammatory state.
This record has no associated files available for download.
More information
e-pub ahead of print date: 31 August 2011
Published date: March 2012
Keywords:
fish oil, human, immune modulation, lipid incorporation, parenteral lipid
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 337192
URI: http://eprints.soton.ac.uk/id/eprint/337192
ISSN: 0014-2972
PURE UUID: d13d7494-57d7-4679-b5a8-ca4e6ce4f48d
Catalogue record
Date deposited: 20 Apr 2012 09:11
Last modified: 15 Mar 2024 03:27
Export record
Altmetrics
Contributors
Author:
Michelle W. Versleijen
Author:
Hennie M. Roelofs
Author:
Charlotte Rombouts
Author:
Peter W. Hermans
Author:
Paul S. Noakes
Author:
Geert J. Wanten
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics